Thursday - April 23, 2026
One in 10 people may have resistance to GLP-1 diabetes drugs
April 10, 2026
STANFORD, California, April 10 -- Stanford University School of Medicine posted the following news:

* * *

One in 10 people may have resistance to GLP-1 diabetes drugs

*

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine scientists and their collaborators.

Th . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products